Skip to main content
Top
Published in: European Journal of Pediatrics 10/2012

01-10-2012 | Review

Monogenic forms of hypertension

Authors: Giacomo Domenico Simonetti, Markus G. Mohaupt, Mario G. Bianchetti

Published in: European Journal of Pediatrics | Issue 10/2012

Login to get access

Abstract

Arterial hypertension in childhood is less frequent as compared to adulthood but is more likely to be secondary to an underlying disorder. After ruling out more obvious causes, some patients still present with strongly suspected secondary hypertension of yet unknown etiology. A number of these children have hypertension due to single gene mutations inherited in an autosomal dominant or recessive fashion. The finding of abnormal potassium levels (low or high) in the presence of suppressed renin secretion, and metabolic alkalosis or acidosis should prompt consideration of these familial diseases. However, mild hypertension and the absence of electrolyte abnormalities do not exclude hereditary conditions. In monogenic hypertensive disorders, three distinct mechanisms leading to the common final pathway of increased sodium reabsorption, volume expansion, and low plasma renin activity are documented. The first mechanism relates to gain-of-function mutations with a subsequent hyperactivity of renal sodium and chloride reabsorption leading to plasma volume expansion (e.g., Liddle's syndrome, Gordon's syndrome). The second mechanism involves deficiencies of enzymes that regulate adrenal steroid hormone synthesis and deactivation (e.g., subtypes of congenital adrenal hyperplasia, apparent mineralocorticoid excess (AME)). The third mechanism is characterized by excessive aldosterone synthesis that escapes normal regulatory mechanisms and leading to volume-dependent hypertension in the presence of suppressed renin release (glucocorticoid remediable aldosteronism). Hormonal studies coupled with genetic testing can help in the early diagnosis of these disorders.
Literature
1.
go back to reference Dave-Sharma S, Wilson RC, Harbison MD et al (1998) Examination of genotype and phenotype relationships in 14 patients with apparent mineralocorticoid excess. J Clin Endocrinol Metab 83:2244–2254PubMedCrossRef Dave-Sharma S, Wilson RC, Harbison MD et al (1998) Examination of genotype and phenotype relationships in 14 patients with apparent mineralocorticoid excess. J Clin Endocrinol Metab 83:2244–2254PubMedCrossRef
2.
go back to reference Dluhy RG, Lifton RP (1995) Glucocorticoid-remediable aldosteronism (GRA): diagnosis, variability of phenotype and regulation of potassium homeostasis. Steroids 60:48–51PubMedCrossRef Dluhy RG, Lifton RP (1995) Glucocorticoid-remediable aldosteronism (GRA): diagnosis, variability of phenotype and regulation of potassium homeostasis. Steroids 60:48–51PubMedCrossRef
3.
go back to reference Ferrari P, Lovati E, Frey FJ (2000) The role of the 11beta-hydroxysteroid dehydrogenase type 2 in human hypertension. J Hypertens 18:241–248PubMedCrossRef Ferrari P, Lovati E, Frey FJ (2000) The role of the 11beta-hydroxysteroid dehydrogenase type 2 in human hypertension. J Hypertens 18:241–248PubMedCrossRef
4.
go back to reference Findling JW, Raff H, Hansson JH et al (1997) Liddle's syndrome: prospective genetic screening and suppressed aldosterone secretion in an extended kindred. J Clin Endocrinol Metab 82:1071–1074PubMedCrossRef Findling JW, Raff H, Hansson JH et al (1997) Liddle's syndrome: prospective genetic screening and suppressed aldosterone secretion in an extended kindred. J Clin Endocrinol Metab 82:1071–1074PubMedCrossRef
5.
go back to reference Gordon RD (1986) Syndrome of hypertension and hyperkalemia with normal glomerular filtration rate. Hypertension 8:93–102PubMedCrossRef Gordon RD (1986) Syndrome of hypertension and hyperkalemia with normal glomerular filtration rate. Hypertension 8:93–102PubMedCrossRef
6.
go back to reference Gordon RD, Geddes RA, Pawsey CG et al (1970) Hypertension and severe hyperkalaemia associated with suppression of renin and aldosterone and completely reversed by dietary sodium restriction. Australas Ann Med 19:287–294PubMed Gordon RD, Geddes RA, Pawsey CG et al (1970) Hypertension and severe hyperkalaemia associated with suppression of renin and aldosterone and completely reversed by dietary sodium restriction. Australas Ann Med 19:287–294PubMed
7.
go back to reference Guyton AC, Coleman TG, Cowley AV Jr et al (1972) Arterial pressure regulation. Overriding dominance of the kidneys in long-term regulation and in hypertension. Am J Med 52:584–594PubMedCrossRef Guyton AC, Coleman TG, Cowley AV Jr et al (1972) Arterial pressure regulation. Overriding dominance of the kidneys in long-term regulation and in hypertension. Am J Med 52:584–594PubMedCrossRef
8.
go back to reference Lifton RP, Dluhy RG, Powers M et al (1992) A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 355:262–265PubMedCrossRef Lifton RP, Dluhy RG, Powers M et al (1992) A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 355:262–265PubMedCrossRef
9.
go back to reference Litchfield WR, Anderson BF, Weiss RJ et al (1998) Intracranial aneurysm and hemorrhagic stroke in glucocorticoid-remediable aldosteronism. Hypertension 31:445–450PubMedCrossRef Litchfield WR, Anderson BF, Weiss RJ et al (1998) Intracranial aneurysm and hemorrhagic stroke in glucocorticoid-remediable aldosteronism. Hypertension 31:445–450PubMedCrossRef
10.
go back to reference Lurbe E, Cifkova R, Cruickshank JK et al (2009) Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension. J Hypertens 27:1719–1742PubMedCrossRef Lurbe E, Cifkova R, Cruickshank JK et al (2009) Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension. J Hypertens 27:1719–1742PubMedCrossRef
11.
go back to reference Martinez-Aguayo A, Aglony M, Campino C et al (2010) Aldosterone, plasma renin activity, and aldosterone/renin ratio in a normotensive healthy pediatric population. Hypertension 56:391–396PubMedCrossRef Martinez-Aguayo A, Aglony M, Campino C et al (2010) Aldosterone, plasma renin activity, and aldosterone/renin ratio in a normotensive healthy pediatric population. Hypertension 56:391–396PubMedCrossRef
12.
go back to reference Milford DV (1999) Investigation of hypertension and the recognition of monogenic hypertension. Arch Dis Child 81:452–455PubMedCrossRef Milford DV (1999) Investigation of hypertension and the recognition of monogenic hypertension. Arch Dis Child 81:452–455PubMedCrossRef
13.
go back to reference Morineau G, Sulmont V, Salomon R et al (2006) Apparent mineralocorticoid excess: report of six new cases and extensive personal experience. J Am Soc Nephrol 17:3176–3184PubMedCrossRef Morineau G, Sulmont V, Salomon R et al (2006) Apparent mineralocorticoid excess: report of six new cases and extensive personal experience. J Am Soc Nephrol 17:3176–3184PubMedCrossRef
14.
go back to reference National high blood pressure education program working group on high blood pressure in children and adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114:555–576CrossRef National high blood pressure education program working group on high blood pressure in children and adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114:555–576CrossRef
15.
go back to reference Nunez BS, Rogerson FM, Mune T et al (1999) Mutants of 11beta-hydroxysteroid dehydrogenase (11-hsd2) with partial activity: improved correlations between genotype and biochemical phenotype in apparent mineralocorticoid excess. Hypertension 34:638–642PubMedCrossRef Nunez BS, Rogerson FM, Mune T et al (1999) Mutants of 11beta-hydroxysteroid dehydrogenase (11-hsd2) with partial activity: improved correlations between genotype and biochemical phenotype in apparent mineralocorticoid excess. Hypertension 34:638–642PubMedCrossRef
16.
go back to reference Rodriguez-Soriano J, Vallo A (1988) Renal tubular hyperkalaemia in childhood. Pediatr Nephrol (Berlin, Germany) 2:498–509CrossRef Rodriguez-Soriano J, Vallo A (1988) Renal tubular hyperkalaemia in childhood. Pediatr Nephrol (Berlin, Germany) 2:498–509CrossRef
17.
go back to reference Shimkets RA, Warnock DG, Bositis CM et al (1994) Liddle's syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel. Cell 79:407–414PubMedCrossRef Shimkets RA, Warnock DG, Bositis CM et al (1994) Liddle's syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel. Cell 79:407–414PubMedCrossRef
18.
go back to reference Spitzer A, Edelmann CM Jr, Goldberg LD et al (1973) Short stature, hyperkalemia and acidosis: a defect in renal transport of potassium. Kidney Int 3:251–257PubMedCrossRef Spitzer A, Edelmann CM Jr, Goldberg LD et al (1973) Short stature, hyperkalemia and acidosis: a defect in renal transport of potassium. Kidney Int 3:251–257PubMedCrossRef
19.
go back to reference Stowasser M, Bachmann AW, Huggard PR et al (2000) Treatment of familial hyperaldosteronism type I: only partial suppression of adrenocorticotropin required to correct hypertension. J Clin Endocrinol Metab 85:3313–3318PubMedCrossRef Stowasser M, Bachmann AW, Huggard PR et al (2000) Treatment of familial hyperaldosteronism type I: only partial suppression of adrenocorticotropin required to correct hypertension. J Clin Endocrinol Metab 85:3313–3318PubMedCrossRef
20.
go back to reference Vehaskari VM (2009) Heritable forms of hypertension. Pediatr Nephrol (Berlin, Germany) 24:1929–1937CrossRef Vehaskari VM (2009) Heritable forms of hypertension. Pediatr Nephrol (Berlin, Germany) 24:1929–1937CrossRef
21.
go back to reference Wilson RC, Krozowski ZS, Li K et al (1995) A mutation in the hsd11b2 gene in a family with apparent mineralocorticoid excess. J Clin Endocrinol Metab 80:2263–2266PubMedCrossRef Wilson RC, Krozowski ZS, Li K et al (1995) A mutation in the hsd11b2 gene in a family with apparent mineralocorticoid excess. J Clin Endocrinol Metab 80:2263–2266PubMedCrossRef
22.
go back to reference Yang CL, Angell J, Mitchell R et al (2003) Wnk kinases regulate thiazide-sensitive Na-Cl cotransport. J Clin Investig 111:1039–1045PubMed Yang CL, Angell J, Mitchell R et al (2003) Wnk kinases regulate thiazide-sensitive Na-Cl cotransport. J Clin Investig 111:1039–1045PubMed
Metadata
Title
Monogenic forms of hypertension
Authors
Giacomo Domenico Simonetti
Markus G. Mohaupt
Mario G. Bianchetti
Publication date
01-10-2012
Publisher
Springer-Verlag
Published in
European Journal of Pediatrics / Issue 10/2012
Print ISSN: 0340-6199
Electronic ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-011-1440-7

Other articles of this Issue 10/2012

European Journal of Pediatrics 10/2012 Go to the issue